Search results
Results from the WOW.Com Content Network
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Massachusetts v. Purdue is a lawsuit filed on August 14, 2018, suing the Stamford, Connecticut-based company Purdue Pharma LP, which created and manufactures OxyContin, "one of the most widely used and prescribed opioid drugs on the market", and Purdue's owners, the Sacklers [1] accusing them of "widespread fraud and deception in the marketing of opioids, and contributing to the opioid crisis ...
OxyContin maker Purdue Pharma is close to a guilty plea agreement on criminal charges tied to its alleged role in fueling the nation's opioid scourge, several sources familiar with the matter told ...
Purdue Pharma’s aggressive marketing of OxyContin, a powerful prescription painkiller that hit the market in 1996, is often cited as a catalyst of a nationwide opioid epidemic, persuading ...
Richard Stephen Sackler (born March 10, 1945) [1] is an American businessman and physician who was the chairman and president of Purdue Pharma, a former company best known as the developer of OxyContin, whose role in the opioid epidemic in the United States became the subject of many lawsuits and fines, filing for bankruptcy in 2019.
This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources. The timeline of the opioid epidemic includes selected events related to the origins of Stamford, Connecticut-based Purdue Pharma, the Sackler family, the development and marketing of oxycodone, selected FDA activities related to the abuse ...
The Supreme Court on Thursday temporarily blocked a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits ...
In 1984, its extended-release formulation of morphine, MS Contin was released. OxyContin was released in 1996 after Curtis Wright, an employee of the Food and Drug Administration [23] approved its use on a 12-hour dosage cycle. [24] Around the time of OxyContin's release, the American Pain Society introduced its "pain as fifth vital sign" campaign.